340 results on '"Aguas, M"'
Search Results
2. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNFα used for the treatment of IBD: Results from the VERNE study
3. Protocolo de manejo de los abscesos intraabdominales en la enfermedad de Crohn
4. DOP80 Prevalence and factors associated with Inflammatory Bowel Disease (IBD) activity during pregnancy: updated data from the DUMBO Registry
5. P1170 Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU
6. P650 Optimization through iv maintenance with ustekinumab in Inflammatory Bowel Disease. Efficacy and adjusted regimen in real world
7. P230 Clinical characteristics, risk factors and management of patients with inflammatory bowel disease and hidradenitis suppurativa: a nationwide multicenter study of the GETECCU ENEIDA registry
8. P493 Do antiTNF or Ustekinumab trough levels correlate with joint extraintestinal manifestations activity in Inflammatory bowel disease patients?
9. P180 Novel biomarkers associated with inflammatory bowel disease
10. P010 Faecal microbiota composition by shotgun metagenomic sequencing approach in a newly diagnosed cohort of inflammatory bowel disease patients: results from the IBDomics project
11. Evaluation of the process of descarnes deliming waste of a process of tanning
12. Post-operative morbidity and mortality of a cohort of steroid refractory acute severe ulcerative colitis: Nationwide multicenter study of the GETECCU ENEIDA Registry
13. Agroindustriales waste impact , management and exploitation
14. P744 Safety of live vaccines in children exposed to biological agents for inflammatory bowel disease (IBD) in utero or during breastfeeding
15. P424 Do antiTNF through levels correlate with joint extraintestinal manifestations (EIM) activity in Inflammatory bowel disease (IBD) patients?
16. P036 Analysis of intestinal tissue from newly diagnosed patients with inflammatory bowel disease reveals distinct proteomic profiles
17. P778 Effectiveness and safety of a second-line rescue therapy for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
18. P652 Therapeutic drug monitoring during induction therapy with Ustekinumab in patients with Crohn's disease: the key to early identification of patients with inadequate response
19. P106 Identification of urine and serum diagnostic biomarkers of inflammatory bowel disease using a proteomic approach
20. P049 Proteomic characterization of serum extracellular vesicles from newly diagnosed patients with inflammatory bowel disease
21. P500 Real life 2 year experience with ustekinumab in a Spanish open-label cohort of ulcerative colitis patients
22. Spontaneous pneumothorax and factors associated with its development in a cohort of COVID-19 patients in Latin America
23. AB1008 CHARACTERIZATION OF THE RISK OF OSTEOPOROSIS IN A COHORT OF RHEUMATIC PATIENTS DURING 10 YEARS OF FOLLOW-UP.
24. AB1071 INFECTIONS IN RHEUMATOLOGIC PATIENTS IN A LATIN AMERICAN HOSPITAL, A 10-YEAR COHORT STUDY.
25. Stem cell therapies for eye conditions: A survey of Australian ophthalmologists
26. Bacteria identified on corneal scrapes demonstrate increasing resistance to fluoroquinolones in New Zealand: Response
27. P607 Post-operative mortality and predictive factors in a cohort of severe refractory ulcerative colitis patients from the ENEIDA Registry (1989–2013): a multicenter nationwide study
28. P480 Characteristics of drug-induced lupus 2° to anti-TNF agents in inflammatory bowel disease patients and evolution after switch to a second anti-TNF
29. P365 Serum adalimumab levels predict successful remission and safe de-intensification in inflammatory bowel disease patients in clinical practice
30. P205 A telemanagement system web in patients with complex inflammatory bowel disease: design and implementation of a randomized clinical trial
31. DOP016 Long-term safety of in utero exposure to anti-tumor necrosis factor for the treatment of inflammatory bowel diseases: results from the multicenter European TEDDY study
32. Recommendations of the Valencian Society of Digestive Pathology for the use of telemedicine and non-contact consultations
33. Evolution of the emotional impact in patients with early inflammatory bowel disease during and after Covid-19 lockdown
34. The characteristics of the stricture, but not the ongoing treatment, could influence the outcome of endoscopic dilation in recurrent Crohn's disease
35. Psychological burden in newly diagnosed IBD patients: Differences between Crohn's Disease and Ulcerative Colitis in early IBD
36. Treatment patterns and intensification within 5 year of follow-up of the first-line anti-TNF alpha used for the treatment of IBD: Results from the VERNE study
37. Delayed diagnosis of inflammatory bowel disease in women: Characterization and use of health resources
38. Surgery Due to Inflammatory Bowel Disease During Pregnancy: Mothers and Offspring Outcomes From an Ecco Confer Multicentre Case Series (Scar Study)
39. Evaluación del efecto de diferentes cepas de levadura (Montrachet, K1-V1116, EC-1118, 71B-1122 y IVC-GRE ®) y clarificantes sobre los atributos sensoriales del vino de naranja criolla (Citrus sinensis)
40. P272 Psychological burden in newly diagnosed IBD patients: Differences between Crohn’s Disease and Ulcerative Colitis in early IBD
41. P487 Surgery due to inflammatory bowel disease during pregnancy: mothers and offspring outcomes (SCAR Study)
42. P545 Safety of ustekinumab in pregnant patients with inflammatory bowel disease and in their offspring: results from the DUMBO registry of GETECCU
43. P018 Proteomic profile of serum and urine in newly diagnosed patients with Inflammatory Bowel Disease: new approach for biomarker discovery
44. P550 Management of immunomodulators and biologic agents in pregnant patients with inflammatory bowel: results from the DUMBO registry of GETECCU
45. P383 Ustekinumab as an opportunity for refractory Ulcerative Colitis patients
46. P169 Delayed diagnosis of inflammatory bowel disease in women: Characterization and use of health resources
47. Letter: management of post-operative Crohnʼs disease - thiopurines vs adalimumab
48. Esteban Rodríguez Garrido: El arte de enseñar
49. Real-Time Visualization of Two-Dimensional Fluid Flow
50. DOP52 Safety of Inflammatory Bowel Disease drugs during pregnancy and breastfeeding: Mothers and babies’ outcomes (DUMBO registry)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.